Abstract
The amyloid precursor protein (APP) is a structurally and functionally conserved transmembrane protein whose physiological role in adult brain function and health is still unclear. Because mutations in APP cause familial Alzheimer’s disease (fAD), most research focuses on this aspect of APP biology. We investigated the physiological function of APP in the adult brain using the fruit fly Drosophila melanogaster, which harbors a single APP homologue called APP Like (APPL). Previous studies have provided evidence for the implication of APPL in neuronal wiring and axonal growth through the Wnt signaling pathway during development. However, like APP, APPL continues to be expressed in all neurons of the adult brain where its functions and their molecular and cellular underpinnings are unknown. We report that APPL loss of function (LOF) results in the dysregulation of endolysosomal function in neurons, with a notable enlargement of early endosomal compartments followed by neuronal cell death and the accumulation of dead neurons in the brain during a critical period at a young age. These defects can be rescued by reduction in the levels of the early endosomal regulator Rab5, indicating a causal role of endosomal function for cell death. Finally, we show that the secreted extracellular domain of APPL interacts with glia and regulates the size of their endosomes, the expression of the Draper engulfment receptor, and the clearance of neuronal debris in an axotomy model. We propose that APP proteins represent a novel family of neuroglial signaling factors required for adult brain homeostasis.
The Amyloid Precursor Protein (APP) is strongly implicated in the etiology of Alzheimer’s disease, but what is its physiological function in the adult brain? This study in Drosophila shows that APP mediates interactions between neurons and glial cells to ensure healthy brain homeostasis.
Introduction
Early-onset familial Alzheimer’s disease (fAD) is caused by several mutations either in the amyloid precursor protein (APP) or in the Presenilin (PSEN-1 and PSEN-2) genes [1,2]. APP is a functionally and structurally conserved transmembrane protein, present in both invertebrates like Caenorhabditis elegans and Drosophila melanogaster [3,4] and mammals [5–7]. APP undergoes 2 competing proteolytic processes: the amyloidogenic processing where it is internalized into endosomes and cleaved by β-secretase and subsequently γ-secretase releasing sAPPβ, the amyloid-β (Aβ) oligomers and APP intracellular domain (AICD), and the non-amyloidogenic processing where APP is cleaved on the cellular membrane by α-secretase and subsequently γ-secretase releasing sAPPα, the P3 domain and AICD [8].
fAD mutations result in the enhancement of the amyloidogenic processing of APP and hence in not only an increased release of Aβ oligomers, but also a reduced production of sAPPα [9] and potentially other unknown effects on APP’s physiological function, such as the balance between its intracellular and extracellular activities. The accumulation of Aβ oligomer aggregates is also present in the brain of patients with sporadic Alzheimer’s disease (AD), forming the Aβ plaques and leading to the hypothesis that Aβ plaques are the main cause of the disease [10]. However, thus far all anti-amyloid treatment, although often successful in reducing the amyloid load, have failed to improve AD symptoms [11]. This raises the need for a better understanding of the physiological function of APP in order to design better future treatment.
In vitro loss of function (LOF) studies on human or mouse APP revealed its involvement in a variety of functions related to neuron biology, such as neural stem cell proliferation, differentiation, and neurite outgrowth of hippocampal neurons [12]. Moreover, it seems to have a role in synapse formation, as a synaptic adhesion molecule [13]. APP’s conserved intracellular domain interacts with many protein-signaling pathways such as the c-Jun N-terminal kinase (JNK) to induce cell death [14], X11/JNK interacting proteins (JIP) to activate cell differentiation [15], and with Fe65 to modulate gene transcription [16].
In D. melanogaster, APP Like (APPL) is the single homologue of the human neuronal APP695 sharing 30% homology at the amino acid level [17]. In vivo LOF studies have demonstrated that APPL is involved in axonal outgrowth during development [18], axonal transport of vesicles or mitochondria [19,20], synapse formation at the neuromuscular junction [21], and long-term and working memory formation [22,23]. Moreover, it has been shown that the secreted portion of APPL (SAPPL) has a neuroprotective function by rescuing vacuole formation in the brain of neurodegenerative mutant flies through its binding to the full-length APPL (flAPPL) [24]. Finally, like in mammals, APPL acts as a receptor and interacts with G0 proteins, cell adhesion molecules, and intracellular modulators like the dX11/Mint protein, Tip60, and Fe65 [25–27].
An interesting observation is that most APP LOF studies in a plethora of neuronal processes and molecular mechanisms reveal relatively mild phenotypes with relatively low penetrance. Combined with the fact that neuronal forms of APP are expressed throughout the brain, this suggests that APP is a homeostasis factor required for the brain to develop correctly, remain stable, and counteract internal and external perturbations. The nervous system encounters several types of genetic mutations and environmental perturbations that can cause organelle stress and cell death and finally can lead to developmental, age, or stress-associated disorders. To counteract this, animals have evolved a defense homeostatic signaling system, composed of protein chaperones and transcriptional mechanisms [28] involving both neurons and glial cells such as astrocytes, Schwann cells, and oligodendrocytes [29]. However, the molecules that neurons use to communicate homeostatic signals to glia remain largely unknown.
A major homeostatic cellular mechanism is the endolysosomal recycling and degradation pathway [30]. This pathway ensures that cellular cargo is properly recycled between the membrane and various organelles or degraded to maintain protein homeostasis and cellular health. A study on primary neurons revealed that an APP intracellular binding protein, PAT-1, regulates the number of early endosomes and endocytosis [31]. Recently, 2 studies revealed that induced pluripotent stem cell (iPSC)-derived human neurons with either APP or PSEN1 fAD knock-in mutations show enlarged and defective early endosomes and lysosomes [32,33]. Therefore, this might suggest a role for APP in the neuronal endolysosomal pathway.
To investigate the in vivo role of APP in neuronal homeostasis, we used Drosophila as a model organism and investigated the consequences of the deletion of its homologue, the Appl gene. We report that loss of APPL results in the increased accumulation of apoptotic cells in the brain at a critical young age. We link this accumulation to defects in the endolysosomal pathway in both neurons and glia and show that APPL is required for neuroglial communication.
Results
APPL is required for neuronal survival in young adult flies
To investigate the implication of APPL in brain health of adult flies, we started with quantifying the survival of APPL null flies (appld) [34] compared to genetic background controls (Canton S) at different stages of their life span. As previously reported [24], appld flies die significantly earlier than their control counterparts in a sex-independent manner starting at 2 to 3 weeks of age (Fig 1A). This suggests that loss of APPL compromises survival at an early age. Because Drosophila APPL is an exclusively neuronal protein [17], we asked whether neuronal health is compromised in APPL mutants during the first 3 weeks of life. We measured the cell death load in the brain of appld and controls at 2, 7, 21, and 45 days of age. To quantify the number of dying cells at any given moment, we stained whole mount brains with Cleaved Drosophila Death caspase protein-1 (Dcp-1), the homologue of human Caspase 3, and manually quantified the Dcp-1 positive cells across the entire central brain (Fig 1B and 1B’). In both genotypes, 2-day-old flies show significant cell death in their brain due to ongoing brain remodeling [35]. By 7 days of age, however, there is a sharp drop in the number of apoptotic cells in controls. In contrast, the drop in apoptosis is significantly reduced in appld flies, with an average of 7 to 8 apoptotic cells per brain at any given time point. Counter staining with the neuronal marker Elav and the glial marker Repo showed that all dying cells detected were neurons (Fig 1B”–1B”“‘). With age, at 21 and 45 days old, both control and appld flies show a similar increase in apoptotic cells (Fig 1C). These data suggest that loss of APPL renders neurons particularly sensitive during the first week of life. APPL is only detectable in neurons, although some reports have claimed it may be expressed in glia [36]. To test whether APPL expression in neurons is required for their survival at 7 days old, we knocked down the expression of APPL using the UAS-Gal4 system expressing APPL RNA interference (RNAi) only in neurons using the pan-neuronal nSyb-Gal4 driver. This resulted in significantly more apoptotic neurons in 7-day-old Appl knock-down flies compared to controls, similar to appld flies (Figs 1D and S1A–S1F’). Furthermore, re-expressing flAPPL or only SAPPL specifically in neurons in an appld background using the pan-neuronal nSyb-Gal4 driver, significantly rescued the increased number of apoptotic cells in the brain of appld flies (Fig 1E). In contrast, overexpressing SAPPL in a control background caused the presence of significantly more apoptotic cells in the brain of 7-day-old flies (Fig 1F).
In summary, our data show that loss of APPL in neurons results in excessive neuronal death during the first week of life and a corresponding reduction in life starting 1 to 2 weeks later. These results also highlight the importance of maintaining the expression of APPL at physiological levels. We next asked by what mechanism APPL acts to protect neurons and flies from premature death.
APPL regulates the size and number of neuronal early endosomes
We have previously shown that APPL is a neuronal modulator of the Wnt planar cell polarity (PCP) pathway for the axonal outgrowth during development. Specifically, loss of APPL sensitizes growing axons to reduction in Wnt PCP signaling and renders the PCP core protein, VanGogh (Vang), haploinsufficient [18]. We started by examining the genetic interaction between appl and vang by removing 1 copy of vang in the appld background and measuring neuronal death at 7 days of age. In contrast to the developmental effect on axon growth, we found no effect on the number of apoptotic neurons (S2 Fig) suggesting a different mechanism.
Studies on fAD mammalian models have described an increased activation of autophagy prior to the appearance of Aβ aggregates [37]. Our in vivo data coincide with the fAD phenotypes as we also observed an increased amount of Atg8 puncta in the central brain of 7-day-old appld flies (S4A and S4B Fig). We conclude that LOF of APPL also causes an accumulation of autophagosomes. However, alterations in autophagy were not linked with the early onset increase in apoptotic cell death, as an Atg7 mutation in appld background flies did not impact the 7-day-old cell death phenotype seen in appld flies (S4C Fig).
A number of observations suggest a tight link between the APP family of proteins and endolysosomal trafficking. First, both human APP and fly APPL carry highly conserved endocytic motifs in their intracellular domains [38], which interact with proteins involved in endocytosis [31]. Second, APP has been implicated in the regulation of the endocytosis of cell surface receptors [39]. Third, as the endolysosomal pathway is involved in APP’s and APPL’s cleavage by β- and γ-secretases, perturbations of the endolysosomal pathway can have negative repercussions in the proteolytic processing of APP and hence the amount of Aβ produced [40]. Fourth, 2 recent in vitro studies showed evidence for the development of enlarged early endosomes and lysosomes in human iPSCs with various fAD mutations in the APP and PSEN1 genes [32,33]. We therefore investigated whether loss of APPL causes defects in endolysosomal function in the brain.
We used an acidification-sensing double fluorescent (DF) probe, composed of a pH-sensitive green fluorescent protein (GFP) (pHluorin) and pH-resistant mCherry fused to a myristoylated residue to track all plasma membrane trafficking (myr-DF) [41]. This probe allows the tracking of the trafficking of membrane cargo through the endolysosomal pathway. In neutral pH vesicles, like early endosomes, the probe will fluoresce in both green and red channels, whereas in acidic vesicles, such as late endosomes and lysosomes, the GFP signal will be quenched and the probe will fluoresce only in red (Fig 2A). Differences in fluorescence values between controls and mutant would indicate potential defects in endolysosomal trafficking. The myr-DF probe was expressed in all neurons, using the nSyb-Gal4 driver, in control and appld flies (Fig 2C and 2C’). We focused our imaging and quantifications on 2 easy-to-identify neuronal populations: the Kenyon cells of the mushroom body and the Projection Neurons of the antennal lobes (Fig 2B). In live confocal imaging data of 7-day-old flies, due to the diffused green signal of pHLuorin, the probe does not distinguish between early and late endosomes, but permits to measure the quantity and volume of the endolysosomal compartments. This analysis revealed the presence of significantly enlarged endolysosomal compartments in the neurons of appld flies compared to those of controls (Figs 2C, 2D, S3A–S3C and S3E).
Live imaging data could only inform us about the trafficking of the protein cargo to an acidic vesicle, with a pH below 6, but not its degradation inside this vesicle [41]. To quantify the effect of APPL LOF on the degradation of plasma membrane protein cargo, we quantified red-only compartments in fixed tissue, where irreversibly damaged pHLuorin leads to the selective loss of green fluorescence [41]. Results from 7-day-old fixed brains showed a marginal but not significant increase in the number of degradative compartments between control and appld brains (Figs 2E and 2E’ and S3D). However, the volume of degradative compartments in appld flies was significantly larger (Fig 2F and 2G). Together, these analyses evoke the possible enlargement of late endosome–like vesicles, suggesting a deficit in the regulation of the volume of endolysosomal compartments in appld flies.
To further investigate these potential defects at higher resolution, we used transmission electron microscopy (TEM) (Fig 3A and 3B). Whereas the overall size of the neuronal cell body did not differ between mutants and controls (Fig 3C), we noted the presence of enlarged clear-single membraned endosome-like vesicles in appld neurons (Fig 3A and 3D). In addition, there were more of them per section than in controls (Figs 3E, 3F, S5A and S5B). On the other hand, lysosomal size did not seem to be affected in appld flies (Figs 3B and 3G, S5C and S5D), and there was a marginal but significant increase in lysosomal number per section (Fig 3H). To verify that APPL expression in neurons is required for the regulation of endosomal size, we knocked down the expression of APPL by expressing APPL RNAi only in neurons using the pan-neuronal nSyb-Gal4 driver. Knocking down the expression of APPL resulted in significantly more cells containing early endosome–like vesicles and significantly larger vesicles compared to controls, similar to appld flies (S5E–S5G Fig). Moreover, using the same UAS-Gal4 system, we also re-expressed, specifically in the neurons of appld flies, the flAPPL and only the SAPPL. Interestingly, re-expressing the flAPPL in appld flies reduced the accumulation of enlarged early endosome–like vesicles to control levels, confirming that the phenotype we observed was caused by the loss of the flAPPL (Fig 4A–4C).
These data confirm the presence of defects in the neuronal endolysosomal pathway in the absence of APPL and suggest that these defects arise mostly in endosomes and are specific to the loss of the flAPPL in neurons suggesting an endogenous regulation of the size of endosomes by APPL.
Our data so far suggest a defective accumulation of enlarged endosomes in neurons of appld flies. The trafficking of cargo from the membrane to early endosomes is regulated by the Rab5 GTPase. To investigate whether defects in early endosomes cause the increase in the number of dying neurons in appl mutant brains, we first examined the expression of Rab5 GTPase in 7-day-old appld flies. Results revealed significantly higher levels of Rab5 in appl mutant brains compared to controls (Fig 5C and 5D), similar to what has previously been reported in AD patients’ fibroblasts [42]. Next, we removed 1 copy of the rab5 gene in an appl null background. This completely rescued the neuronal cell death phenotype at 7 days of age back to control levels (Fig 5A and 5B). We conclude that reducing the trafficking to early endosomes in an appl null condition re-equilibrates the system and rescues the functioning of the endolysosomal pathway.
To test whether the rescue effect is specific to the early endosomal stage, we removed a copy of the gene encoding the late endosomal marker Rab7 in appld mutant background. In contrast to reduction of Rab5 levels, this failed to rescue the number of apoptotic cells found in the brains of 7-day-old appld flies (S4D Fig), and indeed significantly worsened the life span of the flies relative to controls (S4E Fig), consistent with a role for Rab7 itself in neurodegeneration [43].
Our observations suggest that in the absence of APPL, neurons accumulate enlarged vacuole-like endosomal compartments, possibly due to the dysregulation of early endosomes, resulting in neuronal death in the young adult brain. What is intriguing, however, is why these dying neurons accumulate to a sufficient level as to be detectable instead of being cleared by glial cells. We asked whether this accumulation of dying neurons is due only to the dysregulated endolysosomal network, or also to defective glial clearance.
The extracellular domain of APPL is secreted by neurons and interacts with glia
APPL is a transmembrane protein that is cleaved resulting in a secreted form, SAPPL. To explore the expression and secretion pattern of APPL, we generated a double-tagged form of APPL (dT-APPL) with GFP intracellularly (C-terminally) and mCherry extracellularly (N-terminally) (Fig 6A). To study the distribution and spread of SAPPL, we expressed dT-APPL strictly in the retina and imaged the entire brain at different stages of pupal development and in the adult (S6A Fig). Whereas the intracellular part of the appl protein (GFP) remained inside photoreceptors, SAPPL (mCherry) gradually spread throughout the whole brain starting from 80H after puparium formation and remained so in adults (S6A–S6C Fig). Moreover, SAPPL was taken up by glia (S6C Fig). To ascertain that glial uptake of SAPPL was not a consequence of APPL overexpression in the presence of the endogenous protein, we repeated this experiment by expressing the dT-APPL in all post-mitotic neurons of appl null flies. Again, while the intracellular part of APPL remained in neurons, SAPPL was localized both in neurons and in glia (Fig 6B and 6B”‘). To confirm the functionality of the dT-APPL, we re-expressed this form of APPL in appld flies and found that this rescues the developmental axonal defect phenotype in the mushroom bodies reported previously (S6D and S6E Fig) [18].
APPL regulates glial endolysosomal volume and debris clearance function
Considering the involvement of APPL in the regulation of the size of endosomes in neurons, we asked whether SAPPL may play a similar role in glia. We expressed the myr-DF probe specifically in glia and performed live imaging of 7-day-old control and appld brains. In contrast to neurons, the endolysosomal compartments of glia had a reduced volume compared to the controls (Fig 6C, 6C’, and 6D), with no significant effects on their numbers (S7A Fig). The volume and number of degradative compartments analyzed from fixed data was not affected by the absence of APPL (S7B–S7E Fig). TEM analysis, however, revealed some glial disruptions. In control brains, most cortex glia seemed to be intact, and their extensions occupied the spaces between neuronal cell bodies (S7F Fig). In contrast, we occasionally observed irregular distribution of cortex glia between neuronal cell bodies, as well as cytoplasmic blebbing in these glia in APPL null brains, suggesting that glia were either unhealthy and/or dysfunctional in the absence of APPL (S7G Fig). These data suggest the exciting possibility that SAPPL may act as a neuronal signal to regulate endolysosomal trafficking in glia.
Studies on mouse brain lesion models showed increased levels of alpha-secretase A Disintegrin and Metalloprotease (ADAM)-17 and ADAM-10 in reactive astrocytes 7 days post-lesion [44]. In Drosophila, using a model of stabbing of the brain, Kato and colleagues showed that glia lose their ability to react to axonal lesions within 10 days after injury [45]. Therefore, taking into consideration these findings and our data showing a role of APPL during the first week of adulthood in the fly brain and its transfer from neurons to glia, we asked if APPL is required for glia to clear neuronal debris.
To investigate this, we labeled (olfactory receptor neurons) ORNs with GFP in control and appld flies and used the model of antennal ablation [46] (Fig 7A). After ablating both antennae of 5-day-old flies, we dissected their brain and imaged ORN axonal debris (GFP, green) in the antennal lobes of the adult fly brain. In control brains, axonal debris were almost completely cleared by 5 days after ablation. In contrast, loss of APPL caused a significant reduction in the clearance of the degenerative axons by glia in 5 days post-ablation (Fig 7B–7F) (S8 Fig). This defect was rescued by re-expressing, in an appl null background, either flAPPL or only SAPPL specifically in ORNs (Fig 8A–8C). To test the extent of the delay in clearance, we examined control and appl null brains at 8 days post-ablation and found that axonal debris still persist in appl mutants at this late stage (Fig 8D). Therefore, APPL is a neuronal signal required in glia to regulate their ability to clear neuronal debris.
To investigate the mechanism of interaction between APPL and glia and the reason for defective glial clearance of axonal debris, we examined 2 distinct stages of reactive gliosis. Reactive gliosis is the brain’s response to an injury or an infection. It starts with the induction of glial proliferation, migration to the site of injury, and finally, the activation of the glial Draper receptor for the engulfment of degenerating neurons or cellular debris [47].
We started by testing if APPL LOF affects glial migration to the site of the injury in control and appld flies expressing GFP specifically in glia, before and 1 day after antennal ablation. We observed that loss of APPL did not have an impact on the migration of glia around and inside the antennal lobes (S9A–S9C Fig). Next, we examined the induction of the expression of the glial engulfment receptor, Draper, after injury. Although before antennal ablation the levels of Draper were similar in control and appl null brains, loss of APPL resulted in a significantly reduced activation of Draper 1 and 3 days after antennal ablation (Fig 9A–9E).
Discussion
In this study, we took advantage of D. melanogaster to investigate and unravel the physiological function of APPL, the single fly homologue of the human APP, in the adult brain. Our key findings are (1) that APPL is required for neuronal survival during a critical period of early life; (2) that APPL regulates the size of endolysosomal vesicles in neurons and glia; and (3) that secreted APPL interacts with glial cells to enable the clearance of neuronal debris.
APPL is required for adult brain homeostasis through the endolysosomal pathway
A homeostatic signaling system is composed of a set point, a feedback control, sensors, and an error signal. The error signal activates homeostatic effectors to drive compensatory alterations in the process being studied [48]. We propose a model (Fig 10) whereby the presence of APPL and its cleaved forms maintain the physiological flow of vesicular trafficking, either for degradation or for recycling, through the endolysosomal network in neurons. Simultaneously, in case of a system failure, a particular stress or an acute injury, there is an increased release of SAPPL, the error signal, activating degradation in glial cells, the homeostatic effector, to reset the system to its baseline.
It has been observed that appl null flies have a shorter life span and develop large neurodegenerative vacuoles in their brain by 30 days old [24]. In the present study, we demonstrate that the brain of appl null flies shows signs of dysfunctional homeostasis from a much younger age of 7 days old, resulting in a significantly increased number of apoptotic neurons and a significantly increased death rate from 20 days old.
Studies on Down syndrome (Trisomy 21), representing cases of elevated expression of APP, AD patient fibroblasts, AD mouse models, and recent studies using patients iPSCs have all shown evidence of a defective endolysosomal network [32,33,42]. In particular, neurons derived from AD patient iPSCs show that fAD mutations in APP or PSEN1 as well as knockout (KO) of APP, all cause alterations in the endolysosomal vesicle size and functionality. Some of the toxic effects on endolysosomal trafficking have been attributed not to amyloid accumulation but rather to the potential toxicity of the sAPPβ and/or APP β C-terminal fragment (APPβCTF), while a wealth of literature suggests that full-length APP (flAPP) and sAPPα are neuroprotective [24,49].
APPL as a neuronal inducer of glial activity
Glial cells are the key immune responders of the brain that maintain neuronal homeostasis through neurotrophic mechanisms and by clearing degenerating neurons. Our data show that neuronal expression of APPL is necessary and sufficient to activate glial clearance of neuronal debris and that glia take up neuronally released SAPPL. Moreover, we showed that the function of APPL in response to an injury involves regulating the glial engulfment receptor, Draper, via an as of yet unknown mechanism. It has also previously been shown that acute injury of the adult brain elicited an increased expression of APPL at and near the site of injury [50]. Interestingly, a recent study using iPSCs derived astrocytes with APP KO and fAD mutations revealed that loss of flAPP impairs cholesterol metabolism and the ability of astrocytes to clear Aβ protein aggregates [51]. Moreover, up-regulation of APP expression in neurons and α-secretase expression in reactive astrocytes was observed after the denervation of the mouse dentate gyrus [44]. Together, these observations indicate that the expression and proteolytic processing of APP are part of a neuroglial signaling system responsible for monitoring brain health and activating glial responses to neuronal injury. Further future work will be needed to describe how exactly secreted APP fragments are taken up by glia and what cellular and molecular components they interact with and modify within glial cells to mediate appropriate levels of glial activation.
Implications for neurodegeneration
Our findings that the complete loss of the Drosophila APP homologue causes deficits in the endolysosomal pathway, in neuron-induced glial clearance of debris and in neuronal death and organismal life span strongly suggest that, in the adult brain, the physiological function of flAPP and the consequences of fAD mutations are mechanistically related to one another. Furthermore, the fact that neuronal death and defective neuronal endosomes are observed very early in life of appl mutant flies further supports the notion that significant deficits exist in the AD brain long before any clinical symptoms appear. This may suggest that examining the size and/or function of the early endosome may identify risk for future neurodegeneration and offer future treatment pathways.
Materials and methods
Fly stocks and husbandry
Fig 1. Controls: Canton S (+/+;+/+;+/+), yw*;;nsybGal4, w*;UAS CD8 GFP;, yw; + / +; + / + kindly given by the lab of T. Preat. Appl-/-: Appldw*;+/+;+/+ kindly given by the lab of J-M. Dura and y1 sc* v1; P{TRiP.HMS01931}attP40; + / + (UAS Appl RNAi with y+ as a marker) kindly given by the lab of T. Preat. Rescue experiment flies: Appldw*; UAS APPL/+; and Appldw*; UAS SAPPL/+;.
Fig 2. Control: w*;UAS myr mCherry-pHLuorin;, yw*;;nsybGal4. Appl-/-: Appldw*; UAS myr mCherry pH Luorin; nsybGal4 kindly given by the lab of R. Hiesinger.
Fig 3. Controls: Canton S (+/+;+/+;+/+), w*/Y;+/+;+/+. Appl-/-: Appldw*;+/+;+/+.
Fig 5. Rab5-/+: w*;Rab5 KO/CyO; kindly given by the lab of R. Hiesinger.
Fig 6. Control: w*;UAS myr mCherry-pHLuorin;, w*;;repoGal4 kindly given by V. Auld lab. Canton S (+/+;+/+;+/+). Appl-/-: Appldw*;+/+;+/+. Double fluorescent construct: Appldw*hsflp / FM7C Df GmR YFP; UAS CherryApplGFP / CyO; (created in the lab), yw*;;nsybGal4. Appl-/-: Appldw*; UAS myr mCherry pH Luorin; repoGal4.
Fig 7. Control:; OR83bGal4 UAS CD8 GFP; kindly given by the lab of I. Grunwald. Appl-/-: Appldw*/Y;OR83bGal4 UAS CD8 GFP/+;.
Fig 8. Rescue experiment flies: Appldw*; UAS APPL/OR83bGal4GFP; and Appldw*; UAS SAPPL/OR83bGal4GFP;.
S1 Fig. y1 sc* v1; P{TRiP.HMS01931}attP40; + / +, P{KK102543}VIE-260B, yw/Y; UAS CD8 GFP / +; nsybGal4 / +
S2 Fig. Control: w*/Y;+/+;+/+ Appl-/-: w*appld/Y;;, and Vang-/+: appldw*/Y;Vang-/+;.
S4 Fig. Rab7-/+: w*;;Rab7 KO Crispr 3P3RFP/TM6B kindly given by the lab of R. Hiesinger.
S6 Fig. dT expressed specifically in the retina:; UAS-mCherry-APPL-GFP/lexAop-CD4tdGFP; GMR-Gal4/Repo-lexA kindly provided by the lab of R. Hiesinger.
All stocks were maintained using standard rich food at 21°C, and all crosses and experiments were conducted at 25°C on a 15h:9h light:dark cycle at constant humidity.
Life span experiments
For the life span experiment, eclosing adults were collected under CO2-induced anesthesia, over a 12-h period, and were left to mate for 48 h before sorting them into single sexes. After sorting, they were housed at a density of 15 flies per vial. Throughout the life span, flies were kept in a humidified, temperature-controlled, incubator with 15h:9h light:dark cycle at 25°C on a standard, sucrose yeast corn and agar, media. Finally, they were transferred into new food and scored for death every 2 to 3 days throughout adult life [52].
Immunochemistry
Adult brains were dissected in phosphate buffered saline (PBS) and fixed in 3.7% formaldehyde in PBT (PBS+Triton 0.3%) for 15 min. The samples were subsequently rinsed 4 times for 0’, 5’, 15’, and 30’ in PBT 0.3% and blocked in 1% bovine serum albumin (BSA) for at least 1 h. Following these steps, the brains were incubated with the primary antibody diluted in 1% BSA overnight at 4°C. Then, the samples were rinsed 4 times for 0’, 5’, 15’, and 30’ in PBT 0.3% and were subsequently incubated with the appropriate fluorescent secondary antibodies in dark for 2 h at room temperature (RT). Finally, after 4 rinses with PBT 0.3%, the brains were placed in PBS and mounted on a polarized slide using Vectashield (Vector Laboratories, Burlingame, California, United States of America) as the mounting medium. Draper staining was performed as previously described [53].
The mounted fixed brains were imaged on an Olympus 1200 confocal microscope (Olympus France S.A.S., France) equipped with the following emission filters: 490 to 540 nm, 575 to 620 nm, and 665 to 755 nm.
The following antibodies were used: rabbit anti-cleaved Drosophila Dcp-1 (Cell Signaling Technology, Danvers, Massachusetts, USA, 1:100), rat anti-elav (Hybridoma bank, University of Iowa, Department of Biology, Iowa City, Iowa, USA, 1:100), mouse anti-repo (Hybridoma bank, 1:10), rabbit anti-repo (kindly given by Joachim Urban, 1:500), mouse anti-Draper8A1 (Hybridoma bank, 1:400), and mouse anti-nc82 (Hybridoma bank, 1:100).
Transmission electron microscopy
First, we cut 7-day-old Drosophila adult heads and fixed them in 2% glutaraldehyde + 2% paraformaldehyde (PFA) + 1 mM CaCl2 in 0.1-M sodium cacodylate buffer (pH 7.4) for 1 h at RT. Following 3 rinses with sodium cacodylate buffer, we post-fixed samples with 1% osmium tetroxide in the same 0.1-M sodium cacodylate buffer for 1 h at RT. Then, we dehydrated them in a graded series of ethanol solutions (75%, 80%, 90%, and 100%, 10 min each). Final dehydration was performed twice in 100% acetone for 20 min. Subsequently, we infiltrated samples with Epon 812 (epoxy resin) in 2 steps: 1 night at +4°C in a 1:1 mixture of Epon and acetone in an airtight container and 2 h at RT in pure Epon. Finally, we placed samples in molds with fresh resin and cured them in a dry oven at 60°C for 48 h.
Blocs were cut in 1-μm semi-thin sections with an ultramicrotome EM UC7 (Leica, Buffalo Grove, Illinois, USA). Sections were stained with 1% toluidine in borax buffer 0.1 M. Then, we cut ultrathin sections (approximately 70-nm thick) and collected them on copper grid (Electron Microscopy Sciences, Hatfield, Pennsylvania). They were contrasted with Reynolds lead citrate for 7 min. Observations were made with a Hitachi HT 7700 electron microscope (Hitachi, Tokyo, Japan) operating at 70 kV. Electron micrographs were taken using an integrated AMT XR41-B camera (Brickfields Business Park, Suffolk, United Kingdom) (2048 × 2048 pixels).
Adult brain culture and live imaging
Adult brains were dissected in cold Schneider’s Drosophila Medium and mounted in the culture chambers perfused with culture medium and 0.4% dialyzed low-melting agarose [54]. Live imaging was performed at room temperature using a Leica TCS SP8 X confocal microscope (Leica) with a resonant scanner, using 63× water objective (+3.3 zoom). White laser excitation was set to 488 nm for pHLuorin and 587 nm for mCherry signal acquisitions [41].
Quantification and statistical analysis
Imaging data were processed and presented using ImageJ (National Institutes of Health, Bethesda, Maryland, USA). ImageJ was also used for manual quantification of the apoptotic, dcp-1 positive cells slide by slide throughout the z-stack and for selecting regions of interest using the “ROI Manager” function. For the endolysosomal compartments analysis, we used the IMARIS software (Bitplane, Zurich, Switzerland), for both live and fixed images. To quantify the number and volume of the endolysosomal compartments, we used the Surface function, enabling the “Split touching objects” mode and keeping the same intensity threshold across samples and conditions. In the fixed images, to distinguish the red, acidic, compartments from the endosomes and quantify them, we used the “Spot colocalize” function. To measure the volume of the ones non-colocalizing, we used the Surface function enabling the “Split touching objects” mode. Finally, the IMARIS software (Bitplane) and, more specifically, the Surface function, was also used to quantify the volume of remaining GFP expressing axonal debris in the antennal ablation experiment, again using the same intensity threshold across samples and conditions (S9 Fig). Graphs were generated and statistical analysis was conducted using GraphPad Prism 8 (GraphPad Software, San Diego, California, USA).
Olfactory receptor injury protocol
For the antennal ablation experiment, we used; OR83b Gal4 UAS CD8 GFP; flies, expressing GFP in most of the ORNs, and crossed them with control and appld background flies. The progeny of these crosses was collected daily and, after selecting the right genotype, we ablated both antennae of 5-day-old flies using finely sharpened tweezers. Then, we dissected the adult brains at 2, 5, and 8 days post-ablation and followed the immunostaining procedure, as previously described, in dark. We used anti-nc82 as the neuropil antibody in order to better visualize the antennal lobe glomeruli of the adult brain and focus our quantification of the endogenously expressed GFP-covered region accordingly.
Supporting information
Acknowledgments
We thank the Bloomington stock center (NIH P40OD018537) for providing flies used in this study. We thank all members of the Hassan and Hiesinger labs for support and valuable comments. More specifically, we would like to thank Corentine Marie for her help in the illustration of our working model. We are grateful to the ICM imaging facility ICM.Quant for imaging and image analysis support.
Abbreviations
- Aβ
amyloid-β
- AD
Alzheimer’s disease
- ADAM
A Disintegrin and Metalloprotease
- AICD
APP intracellular domain
- APPβCTF
APP β C-terminal fragment
- APP
amyloid precursor protein
- APPL
APP Like
- BSA
bovine serum albumin
- Dcp-1
Cleaved Drosophila Death caspase protein-1
- DF
double fluorescent
- dT-APPL
double-tagged form of APPL
- fAD
familial Alzheimer’s disease
- flAPP
full-length APP
- flAPPL
full-length APPL
- GFP
green fluorescent protein
- iPSCs
induced pluripotent stem cells
- JNK
c-Jun N-terminal kinase
- JIP
JNK interacting proteins
- LOF
loss of function
- Myr-DF
myristoylated double fluorescent
- ORN
olfactory receptor neuron
- PAT-1
Protein interacting with APP tail 1
- PBS
phosphate buffered saline
- PCP
planar cell polarity
- PSEN
Presenilin
- RNAi
RNA interference
- RT
room temperature
- SAPPL
secreted portion of APPL
- TEM
transmission electron microscopy
- Vang
VanGogh
Data Availability
All relevant data are within the paper and its Supporting Information files
Funding Statement
This work was supported by the program “Investissements d’avenir” ANR-10-IAIHU-06 of the Agence Nationale de la Recherche (https://anr.fr/) (to BAH), The Einstein-BIH Visiitng Fellow program EVF-BIH-2015-236-2 (https://www.einsteinfoundation.de/en/programmes/einstein-bih-visiting-fellow) (to BAH), the Paul G. Allen Frontiers Group Allen Disntinguished Investigator Award 12202 (https://alleninstitute.org/what-we-do/frontiers-group) (to BAH), and the Roger De Spoelberch Foundation 2019 Prize (https://www.fondation-roger-de-spoelberch.ch/en) (to BAH), the National Institutes of Health (https://www.nih.gov) RO1EY018884 (to PRH) and the German Research Foundation (https://www.dfg.de) (SFB 958, SFB186) (to PRH)and Freie Universität Berlin (to PRH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PRH received salary form FU Berlin.
References
- 1.Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature. 1991;349 (6311):704–706. 10.1038/349704a0 [DOI] [PubMed] [Google Scholar]
- 2.Clark RF, Hutton M, Fuldner M, Froelich S, Karran E, Talbot C, et al. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet. 1995;11 (2):219–222. 10.1038/ng1095-219 [DOI] [PubMed] [Google Scholar]
- 3.Daigle I, Li C. apl-1, a Caenorhabditis elegans gene encoding a protein related to the human β-amyloid protein precursor. Proc Natl Acad Sci U S A. 1993;90 (24):12045–12049. 10.1073/pnas.90.24.12045 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Rosen DR, Martin-Morris L, Luo L, White K. A Drosophila gene encoding a protein resembling the human β-amyloid protein precursor. Proc Natl Acad Sci U S A. 1989;86 (7):2478–2482. 10.1073/pnas.86.7.2478 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al. The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987;325 (6106):733–736. 10.1038/325733a0 [DOI] [PubMed] [Google Scholar]
- 6.Yoshikai S. ichi, Sasaki H, Doh-ura K, Furuya H, Sakaki Y. Genomic organization of the human amyloid beta-protein precursor gene. Gene. 1990. March 15;87 (2):257–263. 10.1016/0378-1119(90)90310-n [DOI] [PubMed] [Google Scholar]
- 7.Wasco W, Peppercorn J, Tanzi RE. Search for the Genes Responsible for Familial Alzheimer’s Disease. Ann N Y Acad Sci. 1993;695 (1):203–208. 10.1111/j.1749-6632.1993.tb23053.x [DOI] [PubMed] [Google Scholar]
- 8.De Strooper B, Annaert W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci. 2000;113:1857–1870. [DOI] [PubMed] [Google Scholar]
- 9.Cacace R, Sleegers K, Van Broeckhoven C. Molecular genetics of early-onset Alzheimer’s disease revisited Vol. 12, Alzheimer’s and Dementia. Elsevier Inc.; 2016. p. 733–48. 10.1016/j.jalz.2016.01.012 [DOI] [PubMed] [Google Scholar]
- 10.Selkoe DJ. Toward a Comprehensive Theory for Alzheimer’s Disease. Hypothesis: Alzheimer’s Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β-Protein. Ann N Y Acad Sci. 2006;924 (1):17–25. [DOI] [PubMed] [Google Scholar]
- 11.Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 2016;8 (6):595–608. 10.15252/emmm.201606210 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Young-Pearse TL, Chen AC, Chang R, Marquez C, Selkoe DJ. Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1. Neural Dev. 2008;3:15 10.1186/1749-8104-3-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wang Z, Wang B, Yang L, Guo Q, Aithmitti N, Songyang Z, et al. Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis. J Neurosci. 2009;29 (35):10788–10801. 10.1523/JNEUROSCI.2132-09.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kögel D, Schomburg R, Copanaki E, Prehn JHM. Regulation of gene expression by the amyloid precursor protein: Inhibition of the JNK/c-Jun pathway. Cell Death Differ. 2005;12 (1):1–9. 10.1038/sj.cdd.4401495 [DOI] [PubMed] [Google Scholar]
- 15.Biederer T, Cao X, Südhof TC, Liu X. Regulation of APP-dependent transcription complexes by Mint/X11s: Differential functions of Mint isoforms. J Neurosci. 2002;22 (17):7340–7351. 10.1523/JNEUROSCI.22-17-07340.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sumioka A, Nagaishi S, Yoshida T, Lin A, Miura M, Suzuki T. Role of 14-3-3γ in FE65-dependent gene transactivation mediated by the amyloid β-protein precursor cytoplasmic fragment. J Biol Chem. 2005;280 (51):42364–42374. 10.1074/jbc.M504278200 [DOI] [PubMed] [Google Scholar]
- 17.Martin-Morris LE, White K. The Drosophila transcript encoded by the beta-amyloid protein precursor-like gene is restricted to the nervous system. Development. 1990;110(1). [DOI] [PubMed] [Google Scholar]
- 18.Soldano A, Okray Z, Janovska P, Tmejová K, Reynaud E, Claeys A, et al. The Drosophila homologue of the amyloid precursor protein is a conserved modulator of Wnt PCP signaling. PLoS Biol. 2013;11 (5):e1001562 10.1371/journal.pbio.1001562 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Torroja L, Chu H, Kotovsky I, White K. Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport. Curr Biol. 1999;9 (9):489–493. 10.1016/s0960-9822(99)80215-2 [DOI] [PubMed] [Google Scholar]
- 20.Bouleau S, Tricoire H. Drosophila models of Alzheimer’s disease: Advances, limits, and perspectives Vol. 45, J Alzheimers Dis. IOS Press; 2015. p. 1015–38. 10.3233/JAD-142802 [DOI] [PubMed] [Google Scholar]
- 21.Torroja L, Packard M, Gorczyca M, White K, Budnik V. The Drosophila β-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J Neurosci. 1999;19 (18):7793–7803. 10.1523/JNEUROSCI.19-18-07793.1999 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Bourdet I, Preat T, Goguel V. The full-length form of the drosophila amyloid precursor protein is involved in memory formation. J Neurosci. 2015;35 (3):1043–1051. 10.1523/JNEUROSCI.2093-14.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Rieche F, Carmine-Simmen K, Poeck B, Kretzschmar D, Strauss R. Drosophila Full-Length Amyloid Precursor Protein Is Required for Visual Working Memory and Prevents Age-Related Memory Impairment. Curr Biol [Internet]. 2018. March 5 [cited 2020 Feb 7];28(5):817–823.e3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29478851 10.1016/j.cub.2018.01.077 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wentzell JS, Bolkan BJ, Carmine-Simmen K, Swanson TL, Musashe DT, Kretzschmar D. Amyloid precursor proteins are protective in Drosophila models of progressive neurodegeneration. Neurobiol Dis. 2012;46 (1):78–87. 10.1016/j.nbd.2011.12.047 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hase M, Yagi Y, Taru H, Tomita S, Sumioka A, Hori K, et al. Expression and characterization of the Drosophila X11-like/Mint protein during neural development. J Neurochem. 2002;81 (6):1223–1232. 10.1046/j.1471-4159.2002.00911.x [DOI] [PubMed] [Google Scholar]
- 26.Ashley J, Packard M, Ataman B, Budnik V. Fasciclin II signals new synapse formation through amyloid precursor protein and the scaffolding protein dX11/Mint. J Neurosci. 2005;25 (25):5943–5955. 10.1523/JNEUROSCI.1144-05.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Pirooznia SK, Sarthi J, Johnson AA, Toth MS, Chiu K, Koduri S, et al. Tip60 HAT activity mediates APP induced lethality and apoptotic cell death in the CNS of a Drosophila Alzheimer’s disease model. PLoS ONE. 2012;7 (7):e41776 10.1371/journal.pone.0041776 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Panikker P, Xu SJ, Zhang H, Sarthi J, Beaver M, Sheth A, et al. Restoring Tip60 HAT/HDAC2 balance in the neurodegenerative brain relieves epigenetic transcriptional repression and reinstates cognition. J Neurosci. 2018;38 (19):4569–4583. 10.1523/JNEUROSCI.2840-17.2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Fawcett JW, Asher RA. The glial scar and central nervous system repair. Brain Res Bull. 1999;49:377–391. 10.1016/s0361-9230(99)00072-6 [DOI] [PubMed] [Google Scholar]
- 30.Winckler B, Faundez V, Maday S, Cai Q, Almeida CG, Zhang H. The endolysosomal system and proteostasis: From development to degeneration. J Neurosci. 2018;38 (44):9364–9374. 10.1523/JNEUROSCI.1665-18.2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Dilsizoglu Senol A, Tagliafierro L, Gorisse-Hussonnois L, Rebeillard F, Huguet L, Geny D, et al. Protein interacting with Amyloid Precursor Protein tail-1 (PAT1) is involved in early endocytosis. Cell Mol Life Sci. 2019;1 10.1007/s00018-019-03157-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Hung COY, Livesey FJ. Altered γ-Secretase Processing of APP Disrupts Lysosome and Autophagosome Function in Monogenic Alzheimer’s Disease. Cell Rep. 2018;25(13):3647–3660.e2. 10.1016/j.celrep.2018.11.095 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kwart D, Gregg A, Scheckel C, Murphy E, Paquet D, Duffield M, et al. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ. Neuron. 2019;104(2):256–270.e5. 10.1016/j.neuron.2019.07.010 [DOI] [PubMed] [Google Scholar]
- 34.Luo L, Tully T, White K. Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for appl gene. Neuron. 1992;9 (4):595–605. 10.1016/0896-6273(92)90024-8 [DOI] [PubMed] [Google Scholar]
- 35.Kimura KI, Truman JW. Postmetamorphic cell death in the nervous and muscular systems of Drosophila melanogaster. J Neurosci. 1990;10 (2):403–401. 10.1523/JNEUROSCI.10-02-00403.1990 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Farca Luna AJ, Perier M, Seugnet L. Amyloid Precursor Protein in Drosophila Glia Regulates Sleep and Genes Involved in Glutamate Recycling. J Neurosci. 2017;37 (16):4289–4300. 10.1523/JNEUROSCI.2826-16.2017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Franҫois A, Rioux Bilan A, Quellard N, Fernandez B, Janet T, Chassaing D, et al. Longitudinal follow-up of autophagy and inflammation in brain of APPswePS1dE9 transgenic mice. J Neuroinflammation. 2014;11 (1):139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Lai A, Sisodia SS, Trowbridge IS. Characterization of sorting signals in the β-amyloid precursor protein cytoplasmic domain. J Biol Chem. 1995;270 (8):3565–3573. [PubMed] [Google Scholar]
- 39.Zhang F, Gannon M, Chen Y, Zhou L, Jiao K, Wang Q. The amyloid precursor protein modulates α2A-adrenergic receptor endocytosis and signaling through disrupting arrestin 3 recruitment. FASEB J. 2017;31 (10):4434–4446. 10.1096/fj.201700346R [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Nixon RA. Amyloid precursor protein & endosomal-lysosomal dysfunction in Alzheimer’s disease: Inseparable partners in a multifactorial disease. FASEB J. 2017;31 (7):2729–2743. 10.1096/fj.201700359 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Jin EJ, Kiral FR, Ozel MN, Burchardt LS, Osterland M, Epstein D, et al. Live Observation of Two Parallel Membrane Degradation Pathways at Axon Terminals. Curr Biol. 2018;28(7):1027–1038.e4. 10.1016/j.cub.2018.02.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA. Endocytic pathway abnormalities precede amyloid β deposition in sporadic alzheimer’s disease and down syndrome: Differential effects of APOE genotype and presenilin mutations. Am J Pathol. 2000;157 (1):277–286. 10.1016/s0002-9440(10)64538-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Cherry S, Jin EJ, Ozel MN, Lu Z, Agi E, Wang D, et al. Charcot-Marie-Tooth 2B mutations in rab7 cause dosage-dependent neurodegeneration due to partial loss of function. elife. 2013;2:e01064 10.7554/eLife.01064 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Del Turco D, Schlaudraff J, Bonin M, Deller T. Upregulation of APP, ADAM10 and ADAM17 in the denervated mouse dentate gyrus. PLoS One. 2014;9 (1):e84962 10.1371/journal.pone.0084962 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Kato K, Awasaki T, Ito K. Neuronal programmed cell death induces glial cell division in the adult Drosophila brain. Development. 2009;136 (1):51–59. 10.1242/dev.023366 [DOI] [PubMed] [Google Scholar]
- 46.MacDonald JM, Beach MG, Porpiglia E, Sheehan AE, Watts RJ, Freeman MR. The Drosophila Cell Corpse Engulfment Receptor Draper Mediates Glial Clearance of Severed Axons. Neuron. 2006;50 (6):869–881. 10.1016/j.neuron.2006.04.028 [DOI] [PubMed] [Google Scholar]
- 47.J Bradley Zuchero and Ben A Barres Glia in mammalian development and disease. Development. 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Davis GW. Homeostatic signaling and the stabilization of neural function Vol. 80, Neuron. NIH Public Access; 2013. p. 718–28. 10.1016/j.neuron.2013.09.044 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Copanaki E, Chang S, Vlachos A, Tschäpe JA, Müller UC, Kögel D, et al. SAPPα antagonizes dendritic degeneration and neuron death triggered by proteasomal stress. Mol Cell Neurosci. 2010;44 (4):386–393. 10.1016/j.mcn.2010.04.007 [DOI] [PubMed] [Google Scholar]
- 50.Leyssen M, Ayaz D, Hébert SS, Reeve S, De Strooper B, Hassan BA. Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brain. EMBO J. 2005;24 (16):2944–2955. 10.1038/sj.emboj.7600757 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Fong LK, Yang MM, Chaves R. dos S, Reyna SM, Langness VF, Woodruff G, et al. Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid- clearance in human astrocytes. J Biol Chem. 2018;293 (29):11341–11357. 10.1074/jbc.RA117.000441 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Rera M, Clark RI, Walker DW. Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. Proc Natl Acad Sci U S A. 2012;109 (52):21528–21533. 10.1073/pnas.1215849110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Logan Mary and Sean D. Speese In Vivo Analysis of Glial Immune Responses to Axon Degeneration in Drosophila melanogaster. Book: Methods In Molecular Biology. 2020. 10.1007/978-1-0716-0585-1_24 [DOI] [PubMed] [Google Scholar]
- 54.Özel MN, Langen M, Hassan BA, Hiesinger PR. Filopodial dynamics and growth cone stabilization in Drosophila visual circuit development. elife. 2015. October;29:4 10.7554/eLife.10721 [DOI] [PMC free article] [PubMed] [Google Scholar]